Federico D’amario

Dr. Federico D’amario


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FDFederico D’amario
Federico D’amario
LBLuca De Berardinis
Luca De Berardinis
GZGiacomo Zanon
Giacomo Zanon
FQFjorela Qordja
Fjorela Qordja
UVUmberto Vitale
Umberto Vitale
AGAntonio Pompilio Gigante
Antonio Pompilio Gigante
(1) Background: Unicompartmental knee arthroplasty (UKA) provides a viable alternative to total knee arthroplasty (TKA) in patients with isolated medial osteoarthritis (OA). From 2007 to 2021, 23% of all primary knee arthroplasties in Italy were UKAs. We retrospectively evaluated clinical outcomes and satisfaction in patients implanted with a new oxinium metal-backed fixed-bearing medial unicompartmental prosthesis at a 24-month follow-up. (2) Methods: From December 2020 to December 2021, 145 patients were treated by a single surgeon at a single institution using the hypoallergenic Journey II prosthesis. Clinical outcome measures included the Knee Society Knee Score (KSKS), Knee Society Function Score (KSFS), Oxford Knee Society (OKS) score, University of California Los Angeles Activity Score (UCLA), the Physical Component Summary (PCS), and the Mental Component Summary (MCS), and were calculated preoperatively and at 12 and 24 months. The Forgotten Joint Score-12 (FJS-12) was calculated at 12 and 24 months. Patient satisfaction was collected at 24 months. The scores were compared using the Friedman test. (3) Results: All clinical scores improved significantly from baseline to 24 months (p < 0.0001), except for the FJS-12, which from 12 to 24 months did not improve significantly (p = 0.041). Patient satisfaction was 9.32 ± 0.74 out of 10. No patient experienced complications or required revision surgery. (4) Conclusions: The Journey II unicompartmental prosthesis is a valuable treatment option for end-stage medial OA, improving knee function, providing pain relief, and ensuring high patient satisfaction at 24 months.

Verified
Journal Article
Open access
PDF file
FDFederico D’amario
Federico D’amario
UVUmberto Vitale
Umberto Vitale
Ferdinando De DonaFerdinando De Dona
Ferdinando De Dona
LRLuca Ruosi
Luca Ruosi
ACAlessandro Cofone
Alessandro Cofone
MLMattia Loppini
Mattia Loppini
Background: Unicompartmental knee arthroplasty (UKA) is a viable treatment option for patients with isolated knee osteoarthritis. This study evaluated the clinical outcomes of the JII UK (Smith & Nephew, Memphis, TN, USA) hypoallergenic, fixed-bearing UKA implant in a medium cohort of patients undergoing both medial and lateral procedures with a short-term follow-up. Methods: A retrospective review was conducted on 257 consecutive patients who underwent primary UKA using the JII UK implant between December 2020 and December 2022. Clinical outcomes were assessed using the Knee Society Score (KSS), Knee Society Function Score (KSFS), Oxford Knee Score (OKS), UCLA Activity Score, Forgotten Joint Score (FJS-12), and satisfaction. Survivorship analysis was performed, and complications were recorded. Results: At the 2-year follow-up, the implant survival rate was 99.61%. Statistical significant improvements were observed in all clinical scores, with high patient satisfaction. The mean UCLA Activity Score increased from 4.53 preoperatively to 7.3 at 24 months. Conclusions: This study demonstrates promising short-term clinical outcomes for the hypoallergenic fixed-bearing medial and lateral UKA implant, with high patient satisfaction and a low complication rate. Further studies with longer follow-up periods are warranted to confirm these findings.

24 October 2025 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
UVUmberto Vitale
Umberto Vitale
MAMatteo Agarossi
Matteo Agarossi
LRLuca Ruosi
Luca Ruosi
Ferdinando De DonaFerdinando De Dona
Ferdinando De Dona
MLMattia Loppini
Mattia Loppini
FDFederico D’amario
Federico D’amario

31 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
FDFederico D’amario
Federico D’amario
UVUmberto Vitale
Umberto Vitale
Ferdinando De DonaFerdinando De Dona
Ferdinando De Dona
LRLuca Ruosi
Luca Ruosi
ACAlessandro Cofone
Alessandro Cofone
MLMattia Loppini
Mattia Loppini
Background: Unicompartmental knee arthroplasty (UKA) is a viable treatment option for patients with isolated knee osteoarthritis. This study evaluated the clinical outcomes of the JUK II (Smith & Nephew, Memphis, TN, US) hypoallergenic, fixed-bearing UKA implant in a medium cohort of patients undergoing both medial and lateral procedures with a short-term follow-up. Methods: A retrospective review was conducted on 257 consecutive patients who underwent primary UKA using the JUK II implant between December 2020 and December 2022. Clinical outcomes were assessed using the Knee Society Score (KSS), Knee Society Function Score (KSFS), Oxford Knee Score (OKS), UCLA Activity Score, Forgotten Joint Score (FJS-12) and the satisfaction. Survivorship analysis was performed, and complications were recorded. Results: At a 2-year follow-up, the implant survival rate was 99.61%. Statistical significant improvements were observed in all clinical scores, with high patient satisfaction. The mean UCLA Activity Score increased from 4.53 preoperatively to 7.3 at 24 months. Conclusions: This study demonstrates promising short-term clinical outcomes for the hypoallergenic fixed-bearing medial and lateral UKA implant, with high patient satisfaction and a low complication rate. Further studies with longer follow-up periods are warranted to confirm these findings.